Divarasib (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of <0.01 µM. Divarasib irreversibly locks KRAS G12C oncoprotein in an inactive state and inhibits tumor cell growth. It is being investigated for use in solid tumors, including non-small cell lung and colorectal cancers and other types of cancer.
Molecular Weight:
622.06
Purity:
99.96%
CAS Number:
[2417987-45-0]
Formula:
C29H32ClF4N7O2
Target:
Ras|||Kras
T9972
* VAT and and shipping costs not included. Errors and price changes excepted
